There was jubilation at the start of the week when Oxford University announced the results from phase three of their vaccine trials. The new vaccine, the university said, offers a high level of protection against COVID-19. But since then, scientists in the UK and the US have been asking questions — and some are worried that the drug may not be as effective as hoped. The World’s Orla Barry reports from London.